## Abstract The objective of this study was to assess the factors implicated in an increased or decreased risk of pneumonia, with particular attention to the response to highly active antiretroviral therapy (HAART) and the effect of the polysaccharide 23βvalent pneumococcal vaccination in 300 human
Modeling the impact of imperfect HIV vaccines on the incidence of the infection
β Scribed by E. Massad; F.A.B. Coutinho; M.N. Burattini; L.F. Lopez; C.J. Struchiner
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 385 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0895-7177
No coin nor oath required. For personal study only.
β¦ Synopsis
One concern about HIV vaccine trials is that participants might develop a false sense of security and increase their risk behavior. This fear has (at least partially) impaired the development of extensive clinical trials on HIV vaccines and are, in principle, justified. In this paper, we develop a dynamical model which allows experiments on the effects of an imperfect vaccine on a population prone to change its risk behavior. Our results show that even the poorest of the candidate vaccines to be seriously considered, may have beneficial effects on reducing transmission, even when risk behaviors increases. (~) 2001 Elsevier Science Ltd. All rights reserved.
π SIMILAR VOLUMES
## Abstract Vaccines based on human papillomavirus (HPV) 16 and 18 virusβlike particles have the potential to prevent βΌ70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and includes routine vaccination of females aged 12β13 years, and a 2βyear school and
A simple deterministic model is proposed to represent the basic aspects concerning the effects of different antiretroviral treatment schedules on HIV incidence and prevalence of affected populations. The model mimics current treatment guidelines applied in Brazil. However, the model does not intend
Two possible dangers of an extensive varicella vaccination program are more varicella (chickenpox) cases in adults, when the complication rates are higher, and an increase in cases of zoster (shingles). Here an age-structured epidemiologic-demographic model with vaccination is developed for varicell